Angela Schulz

Study of Intraventricular Cerliponase Alfa for CLN2 Disease

Angela Schulz, Temitayo Ajayi, Nicola Specchio et al. · New England Journal of Medicine · 2018 · 456 citations

NCL diseases — clinical perspectives

Angela Schulz, Alfried Kohlschütter, Jonathan W. Mink et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2013 · 242 citations

Clinical Disorders, — Clinical Perspectives, Disease Mechanism +8

Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study

Miriam Nickel, Alessandro Simonati, David Jacoby et al. · The Lancet Child & Adolescent Health · 2018 · 129 citations · Full text

Disease Characteristics, Pediatrics, Pathology +4

Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis

Michael Fietz, Moeenaldeen AlSayed, Derek Burke et al. · Molecular Genetics and Metabolism · 2016 · 97 citations · Full text

Creutzfeldt-jakob Disease, Neurological Disorder, Expert Recommendations +16

The CLN9 Protein, a Regulator of Dihydroceramide Synthase

Angela Schulz, Talal Mousallem, Maya Venkataramani et al. · Journal of Biological Chemistry · 2005 · 88 citations · Full text

Apoptosis, Molecular Biology, Pathology +18